Late adjunctive therapy with single doses of rapamycin in skin-allografted mice treated with antilymphocyte serum and donor bone marrow cells

Transplant Immunology

Volumn 4, Issue 2, 1996, Pages 105-112

  De Fazio, Sally R ^a   Plowey, Jeffrey M ^a   Hartner, William C ^a   Gozzo, James J ^a  

^a NORTHEASTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

15 DEOXYSPERGUALIN; CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; LYMPHOCYTE ANTIBODY; RAPAMYCIN;

ANIMAL EXPERIMENT; ARTICLE; BONE MARROW CELL; GRAFT SURVIVAL; IMMUNOLOGICAL TOLERANCE; IMMUNOSUPPRESSIVE TREATMENT; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN ALLOGRAFT; SPLEEN CELL;

EID: 0030175045     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0966-3274(96)80003-7     Document Type: Article

References (23)

1. Monaco A.P, Wood M.L, Maki T, Gozzo J.J. Post transplantation donor-specific bone marrow transfusion in polyclonal antilymphocyte serum-treated recipients: the optimal cellular antigen for induction of unresponsiveness to organ allografts. Transplant Proc. 20:1988;1207-1212.
2. Hartner W.C, De Fazio S.R, Markees T.G, Maki T, Monaco A.P, Gozzo J.J. Specific tolerance to canine renal allografts following treatment with fractionated bone marrow and antilymphocyte serum. Transplant Proc. 19:1987;476-477.
3. Hartner W.C, Markees T.G, De Fazio S.R, et al. The effect of anti-lymphocyte serum, fractionated donor bone marrow, and cyclosporine on renal allograft survival in mongrel dogs. Transplantation. 52:1991;784-789.
4. Thomas J.M, Carver F.M, Foil M.B, et al. Renal allograft tolerance induced with ATG and donor bone marrow in outbred rhesus monkeys. Transplantation. 36:1993;104-106.
5. Thomas J.M, Carver M, Cunningham P, Sash C, Park K, Thomas F. Promotion of incompatible allograft acceptance in rhesus monkeys given posttransplant antithymocyte globulin and donor bone marrow: II. Effects of adjuvant immunosuppressive drugs. Transplantation. 47:1989;209-215.
6. Barber W.H, Mankin J.A, Laskow S.A, et al. Long-term results of a controlled prospective study with transfusion of donor-specific bone marrow in 57 cadaveric renal allograft recipients. Transplantation. 51:1991;70-75.
7. Jamshidi F, De Fazio S.R, Markees T.G, Gozzo J.J. Induction of allograft tolerance with neonatal skin. Transplantation. 51:1991;1048-1052.
8. De Fazio S.R, Gozzo J.J. Prolongation of skin allograft survival by cotransplantation of UVB-irradiated skin. Transplantation. 58:1994;1044-1047.
9. Wood M.L, Gottschalk R, Monaco A.P. The effect of cyclosporine on the induction of unresponsiveness in antilymphocyte serum-treated, marrow-injected mice. Transplantation. 46:1988;449-451.
10. Bobbio S.A, Wood M.L, Monaco A.P. Significant augmentation of specific unresponsiveness by rapamycin in ALS-treated, bone marrow-injected mice. Transplant Sci. 3:1993;51-55.
11. Hartner W.C, van der Werf W.J, Gilchrist B, et al. Effect of rapamycin on renal allografted dogs treated with ALS, CSA, and donor BMC. Transplantation. 60:1995;1347-1350.
12. Wood M.L, Monaco A.P. The effect of cyclophosphamide on the specific unresponsiveness to skin allografts induced in ALS-treated mice infused with donor bone marrow. J Immunol. 118:1977;1456-1459.
13. Morris R.E. Rapamycins: antifungal, antitumor, antiproliferative, and immunosuppressive macrolide. Transplant Rev. 6:1992;39-87.
14. De Fazio S.R, Plowey J, Hartner W.C, Gozzo J.J. Effect of single-dose, late treatment with rapamycin on skin allograft survival in ALS- and donor BMC-treated mice. Transplant Proc. 26:1994;3102-3103.
15. Billingham R.E, Medawar P. The technique of free skin grafting in mammals. J Exp Biol. 28:1951;385.
16. Litchfield J.T. A method for rapid graphic solution of time-percent curves. J Pharmacol Exp Ther. 97:1949;399-408.
17. Gozzo J.J, Wood M.L, Monaco A.P. Studies on ALS in mice: VIII. Effect of immunizing cell type and dose on immunosuppressive potency and content of irrelevant antibody. Transplantation. 14:1972;352-357.
18. Wood M.L, Monaco A.P. Suppressor cells in specific unresponsiveness to skin allografts in ALS-treated, marrow-injected mice. Transplantation. 29:1980;196-200.
19. Ferraresso M.R, Ghobrial R, Stepkowski S.M, Kahan B.D. Mechanism of unresponsiveness to allografts induced by rapamycin and rapamycin/cyclosporine treatment in rats. Transplantation. 55:1993;888-894.
20. Ferraresso M.R, Tian L, Ghobrial R, Stepkowski S.M, Kahan B.D. Rapamycin inhibits production of cytotoxic but not noncytotoxic antibodies and preferentially activates T helper 2 cells that mediate long-term survival of heart allografts. J Immunol. 153:1994;3307-3318.
21. Fryer J, Yatscoff R.W, Pascoe E.A, Thilveris J. The relationship of blood concentrations of rapamycin and cyclosporine to suppression of allograft rejection in a rabbit heterotopic heart transplant model. Transplantation. 55:1993;340-345.
22. Kahan B.D, Gibbons S, Tejpal N, Stepkowski S.M, Chou T.C. Synergistic interactions of cyclosporine and rapamycin to inhibit immune performances of normal human lymphocytes in vitro. Transplantation. 51:1991;232-239.
23. Yuh D.D, Morris R.E. The immunopharmacology of immunosuppression by 15-deoxyspergualin. Transplantation. 55:1993;578-591.